Is T2 non-small cell lung cancer located in left lower lobe appropriate to upstage?

Interactive Cardiovascular and Thoracic Surgery

Volumn 4, Issue 2, 2005, Pages 126-129

  Iwasaki, Akinori ^a   Shirakusa, Takayuki ^a   Enatsu, Sotarou ^a   Maekawa, Shinichi ^a   Yoshinaga, Yasuteru ^a   Yoneda, Satoshi ^a   Hoshino, Seiichiro ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

Histological differentiation; Left lower lobe; T2 NSCLC

Indexed keywords

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; LUNG ADENOCARCINOMA; LUNG HILUS; LUNG LOBE; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LYMPH NODE; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; MULTIVARIATE ANALYSIS; PATIENT; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; SURVIVAL TIME; TUMOR DIFFERENTIATION; TUMOR VOLUME;

EID: 24744452841     PISSN: 15699293     EISSN: None     Source Type: Journal    
DOI: 10.1510/icvts.2004.104380     Document Type: Article

References (15)

1. Carbone E, Asamura H, Takei H, Kondo H, Suzuki K, Miyaoka E, Tsuchiya R, Motta G. T2 tumors larger than five centimeters in diameter can be upgraded to T3 in non-small cell lung cancer. J Thorac Cardiovasc Surg 2001;122:907-912.
2. Watanabe Y, Shimizu J, Oda M, Hayashi Y, Iwa T, Nonomura A, Kamimura R, Takashima T. Proposal regarding some deficiencies in the new international staging system for non-small cell lung cancer. Jpn J Clin Oncol 1991;21:160-168.
3. Shimizu K, Yoshida J, Nagai K, Nishimura M, Yokose T, Ishii G, Nishiwaki Y. Visceral pleural invasion classification in non-small cell lung cancer: proposal on the basis of outcome assessment. J Thorac Cardiovasc Surg 2004;127:1574-1578.
4. Kang JH, Kim KD, Chung KY. Prognostic value of visceral pleura invasion in non-small cell lung cancer. Eur J Cardiothorac Surg 2003;23:865-869.
5. Keller SM, Vangel MG, Wagner H, Schiller JH, Herskovic A, Komaki R, Marks RS, Perry MC, Livingston RB, Johnson DH; Eastern Cooperative Oncology Group. Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease. J Thorac Cardiovasc Surg 2004;128:130-137.
6. Misthos P, Sepsas E, Athanassiadi K, Kakaris S, Skottis I. Skip metastases: analysis of their clinical significance and prognosis in the IIIA stage of non-small cell lung cancer. Eur J Cardiothorac Surg 2004;25:502-508.
7. Inoue M, Sawabata N, Takeda S, Ohta M, Ohno Y, Maeda H. Results of surgical intervention for p-stage IIIA (N2) non-small cell lung cancer: acceptable prognosis predicted by complete resection in patients with single N2 disease with primary tumor in the upper lobe. J Thorac Cardiovasc Surg 2004;127:1100-1106.
8. Watanabe Y, Shimizu J, Oda M, Hayashi Y, Iwa T, Nonomura A. Proposal regarding some deficiencies in the New International Staging System for non-small cell lung cancer. Jpn J Clin Oncol 1991;21:160-168.
9. Lafitte JJ, Ribet ME, Prevost BM, Gosselin BH, Copin MC, Brichet AH. Postresection irradiation for T2 N0 M0 non-small cell carcinoma: a prospective, randomized study. Ann Thorac Surg 1996;62:830-304.
10. van Velzen E, Snijder RJ, Brutel de la Riviere A, Elbers HR, van den Bosch JM. Lymph node type as a prognostic factor for survival in T2 N1 M0 non-small cell lung carcinoma. Ann Thorac Surg 1997;63:1436-1440.
11. Osaki T, Nagashima A, Yoshimatsu T, Tashima Y, Yasumoto K. Survival and characteristics of lymph node involvement in patients with N1 nonsmall cell lung cancer. Lung Cancer 2004;43:151-157.
12. Ichinose Y, Kato H, Koike T, Tsuchiya R, Fujisawa T, Shimizu N, Watanabe Y, Mitsudomi T, Yoshimura M, Tsuboi M; Japanese Clinical Oncology Group. Completely resected stage IIIA non-small cell lung cancer: the significance of primary tumor location and N2 station. J Thorac Cardiovasc Surg 2001;122:803-808.
13. Rocha AT, McCormack M, Montana G, Schreiber G. Association between lower lobe location and upstaging for early-stage non-small cell lung cancer. Chest 2004;125:1424-1430.
14. Canadian Lung Oncology Group. Investigation for mediastinal disease in patients with apparently operable lung cancer. Ann Thorac Surg 1995;60:1382-1389.
15. Prenzel KL, Monig SP, Sinning JM, Baldus SE, Gustshow CA, Grass G, Schneider PM, Holscher AH. Role of skip metastasis to mediastinal lymph nodes in non-small cell lung cancer. J Surg Oncol 2003; 82:256-260.